Optibrium celebrates growth in all areas of
the company as it enters its fourth year of business
Optibrium, developer of software solutions for drug discovery, today reveals an exciting period of growth across all areas of its business. Optibrium is celebrating significant expansion in its team of experts, requiring relocation to new, larger premises. This success is built on the rapidly expanding, global customer base for Optibrium’s primary product, StarDrop. This pioneering drug discovery software platform offers a range of intuitive tools and technologies that guide the selection and design of high quality compounds in drug discovery.
Optibrium, which was founded in 2009, now boasts a customer base of over 50 pharma, biotech and academic groups spread across the globe, including seven of the top ten pharmaceutical companies. All have been attracted by StarDrop; a highly visual and easy-to-use software package, which provides a unique environment for multi-parameter optimisation of candidate drugs. It includes an interactive designer that helps to explore optimisation strategies, guided by StarDrop’s unique Glowing Molecule visualisation. The suite is complemented by a range of plug-in modules that further expand its capabilities to quickly identify better molecules, thereby reducing costs and timelines and strengthening pipelines. Reflecting the growth of the business, Optibrium has expanded its software development and support teams to maintain the high level of support provided to its users and this has required the company to move to office space which is 50% larger than its original premises.
The most recent appointment has seen Nick Foster join as Director of Business Development. Nick’s role will see him lead the development of new business opportunities for Optibrium’s products. Nick has 20 years of experience within the life science industry and academia and joins Optibrium from BioFocus. Nick’s successful track record in business development is complemented by his early scientific career, spent as an ADME/PK scientist working on drug discovery projects.
Nick comments, “I am delighted to be joining the Optibrium team. The company has a fantastic reputation in the industry for its innovative products and offers a dynamic place to work. I look forward to developing our customer base and being part of Optibrium’s continuing expansion and success.”
CEO Matt Segall comments, “Over the past three years our team has developed our product portfolio and introduced innovative approaches to drug discovery as we expanded our customer base. We have now reached a really exciting phase of rapid growth as the result of this hard work and this provides further inspiration to the whole team who are dedicated to finding ways to help scientists to optimise drug discovery.”
Optibrium is offering StarDrop users the opportunity to win a trip to the American Chemical Society (ACS) Spring National Meeting and Exhibition 2013 in New Orleans, Louisiana. For more information please visit http://www.optibrium.com/news/competition.php.
For more information about StarDrop and Optibrium’s software solutions please visit www.optibrium.com, alternatively please call +44 (0) 1223 815 900 or email info@optibrium.com.
END
About Optibrium Ltd
Optibrium (www.optibrium.com) is dedicated to providing software to guide decisions involving complex, uncertain data in an intuitive way. Based in Cambridge, UK, Optibrium has a global customer base ranging from top-ten pharmaceutical companies to biotechs and academic groups. Our mission is to continue to develop new technologies that will optimise project strategy, reduce wasted molecules and experiments, shorten timelines and improve the quality of candidate compounds for our clients. Optibrium’s primary product, StarDrop, is focused on the drug discovery industry, helping guide scientists to make decisions in the design and selection of high quality drug candidates. Visit the online community at http://www.optibrium.com/community/ for further discussions on improving the productivity of drug discovery.
For further press information please contact: Sarah Morley, The Scott Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire CW4 8AA, UK Tel: + 44 1477 539539 Fax: +44 1477 539 540 E-mail: optibrium@scottpr.com
No comments:
Post a Comment